Insmed Incorporated
INSM
Rang în acțiuni
#1117
Insmed Incorporated operates as a biopharmaceutical enterprise focused on... Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.
Preț acțiune
$95.40
Capitalizare de piață
$20.83B
Schimbare (1 zi)
0.12%
Schimbare (1 an)
-43.18%
Țară
US
Tranzacționează Insmed Incorporated (INSM)
Categorie
Healthcare
Istoricul spliturilor pentru Insmed Incorporated (INSM)
Acțiunea Insmed Incorporated (simbol: INSM) a trecut printr-un total de 2 splituri.
Cel mai recent split a avut loc pe Mar 03, 2011.
O acțiune INSM cumpărată înainte de Jul 31, 2000 este echivalentă astăzi cu 0.025 acțiuni INSM.
Cel mai recent split a avut loc pe Mar 03, 2011.
O acțiune INSM cumpărată înainte de Jul 31, 2000 este echivalentă astăzi cu 0.025 acțiuni INSM.
Listă splituri acțiuni
| An | Split | Multiplu | Multiplu cumulativ |
|---|---|---|---|
| 2011-03-03 | 1:10 | x0.1 | x0.025 |
| 2000-07-31 | 1:4 | x0.25 | x0.25 |
Splituri pentru companii similare sau competitori
| Companie | Număr total de splituri | Multiplu cumulativ | Țara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
